These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 36108823)

  • 21. Limb-Based Patency After Surgical vs Endovascular Revascularization in Patients with Chronic Limb-Threatening Ischemia.
    Utsunomiya M; Takahara M; Iida O; Soga Y; Hata Y; Shiraki T; Nagae A; Kato T; Kobayashi N; Suematsu N; Tasaki J; Horie K; Uchida D; Kodama A; Azuma N; Nakamura M
    J Endovasc Ther; 2020 Aug; 27(4):584-594. PubMed ID: 32431246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amputation-free survival, limb symptom alleviation, and reintervention rates after open and endovascular revascularization of femoropopliteal lesions in patients with chronic limb-threatening ischemia.
    Perlander A; Jivegård L; Nordanstig J; Svensson M; Österberg K
    J Vasc Surg; 2020 Dec; 72(6):1987-1995. PubMed ID: 32276010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contemporary (2009-2014) clinical outcomes after femoropopliteal bypass surgery for chronic limb threatening ischemia are inferior to those reported in the UK Bypass versus Angioplasty for Severe Ischaemia of the Leg (BASIL) trial (1999-2004).
    Meecham L; Popplewell M; Bate G; Patel S; Bradbury AW
    J Vasc Surg; 2019 Jun; 69(6):1840-1847. PubMed ID: 30852037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment outcomes between bypass surgery and endovascular therapy in patients with chronic limb-threatening ischemia classified as bypass-preferred category based on Global Vascular Guidelines.
    Morisaki K; Matsuda D; Guntani A; Matsubara Y; Kinoshita G; Kawanami S; Yamashita S; Honma K; Furuyama T; Yamaoka T; Mii S; Komori K; Yoshizumi T
    J Vasc Surg; 2023 Aug; 78(2):475-482.e1. PubMed ID: 37076109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical outcomes of bypass-first versus endovascular-first strategy in patients with chronic limb-threatening ischemia due to infrageniculate arterial disease.
    Dayama A; Tsilimparis N; Kolakowski S; Matolo NM; Humphries MD
    J Vasc Surg; 2019 Jan; 69(1):156-163.e1. PubMed ID: 30579443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endovascular Therapy Provides Similar Results of Bypass Graft Surgery in the Treatment of Infrainguinal Multilevel Arterial Disease in Patients with Chronic Limb-Threatening Ischemia in All GLASS Stages.
    Casella IB; Sartori CH; Faustino CB; Vieira Mariz MP; Presti C; Puech-Leão P; De Luccia N
    Ann Vasc Surg; 2020 Oct; 68():400-408. PubMed ID: 32339688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of Long Term Outcomes After Endovascular Treatment Versus Bypass Surgery in Chronic Limb Threatening Ischaemia Patients with Long Femoropopliteal Lesions.
    Zlatanovic P; Mahmoud AA; Cinara I; Cvetic V; Lukic B; Davidovic L
    Eur J Vasc Endovasc Surg; 2021 Feb; 61(2):258-269. PubMed ID: 33334672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of infrapopliteal vein bypass graft revision in patients with chronic limb-threatening ischemia.
    Kawai Y; Kodama A; Sato T; Ikeda S; Tsuruoka T; Sugimoto M; Niimi K; Banno H; Komori K
    Vascular; 2024 Feb; 32(1):65-75. PubMed ID: 36042581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Infrapopliteal Anatomic Severity and Delayed Wound Healing in Patients With Chronic Limb-Threatening Ischemia in the Era of the Global Limb Anatomic Staging System.
    Hata Y; Iida O; Takahara M; Asai M; Masuda M; Okamoto S; Ishihara T; Nanto K; Kanda T; Tsujimura T; Okuno S; Matsuda Y; Mano T
    J Endovasc Ther; 2020 Aug; 27(4):641-646. PubMed ID: 32571134
    [No Abstract]   [Full Text] [Related]  

  • 30. Validation of Global Limb Anatomical Staging System (GLASS) in patients with hemodialysis and Chronic Limb-Threatening Ischemia after endovascular treatment.
    Tokuda T; Oba Y; Koshida R; Kagase A; Matsuda H; Suzuki Y; Murata A; Ito T
    Heart Vessels; 2021 Jun; 36(6):809-817. PubMed ID: 33386921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eligibility of Patients with Chronic Limb Threatening Ischemia for Deep Venous Arterialization.
    Satam K; Aboian E; Huttler J; Zhuo H; Zhang Y; Tonnessen B; Cardella J; Guzman RJ; Ochoa Chaar CI
    Ann Vasc Surg; 2022 Oct; 86():260-267. PubMed ID: 35589034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A systematic review and meta-analysis of revascularization outcomes of infrainguinal chronic limb-threatening ischemia.
    Almasri J; Adusumalli J; Asi N; Lakis S; Alsawas M; Prokop LJ; Bradbury A; Kolh P; Conte MS; Murad MH
    Eur J Vasc Endovasc Surg; 2019 Jul; 58(1S):S110-S119. PubMed ID: 31221539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of Amputation-free Survival after Endovascular Intervention for Chronic Limb-Threatening Ischemia in the Modern era.
    Joshi GS; Zhang SM; Wang K; El Khoury R; Cataneo J; Jacobs CE; White JV; Schwartz LB
    Ann Vasc Surg; 2022 Oct; 86():268-276. PubMed ID: 35595207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Real Life Outcomes of Infrapopliteal Endovascular and Surgical Bypass Intervention for Chronic Limb Threatening Ischaemia in GLASS Stages II and III.
    Rossi FH; Giusti JCG; Cury MVM; Beraldo JPN; Brochado Neto FC; Kambara AM
    Eur J Vasc Endovasc Surg; 2022 Jul; 64(1):41-48. PubMed ID: 35537642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A systematic review and meta-analysis of GLASS staging system in the endovascular treatment of chronic limb-threatening ischemia.
    Bontinis V; Bontinis A; Koutsoumpelis A; Giannopoulos A; Ktenidis K
    J Vasc Surg; 2023 Mar; 77(3):957-963.e3. PubMed ID: 35953002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implications of early failure of isolated endovascular tibial interventions.
    Cheun TJ; Jayakumar L; Ferrer L; Miserlis D; Mitromaras C; Sideman MJ; Davies MG
    J Vasc Surg; 2020 Jul; 72(1):233-240.e2. PubMed ID: 32035771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Society for Vascular Surgery Wound, Ischemia, foot Infection (WIfI) score correlates with the intensity of multimodal limb treatment and patient-centered outcomes in patients with threatened limbs managed in a limb preservation center.
    Robinson WP; Loretz L; Hanesian C; Flahive J; Bostrom J; Lunig N; Schanzer A; Messina L
    J Vasc Surg; 2017 Aug; 66(2):488-498.e2. PubMed ID: 28410924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes for peripheral vascular intervention and lower extremity bypass in kidney transplant recipients are superior to outcomes of patients remaining on dialysis.
    King RW; Malas MB; Brothers TE
    J Vasc Surg; 2019 Jun; 69(6):1849-1862.e6. PubMed ID: 30583898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes of infrageniculate retrograde versus transfemoral access for endovascular intervention for chronic lower extremity ischemia.
    Taha AG; Abou Ali AN; Al-Khoury G; Singh MJ; Makaroun MS; Avgerinos ED; Chaer RA
    J Vasc Surg; 2018 Oct; 68(4):1088-1095. PubMed ID: 29615358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Results for primary bypass versus primary angioplasty/stent for lower extremity chronic limb-threatening ischemia.
    Darling JD; McCallum JC; Soden PA; Korepta L; Guzman RJ; Wyers MC; Hamdan AD; Schermerhorn ML
    J Vasc Surg; 2017 Aug; 66(2):466-475. PubMed ID: 28274753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.